Subscribe: Market Wire - Medical and Healthcare: Surgery and Treatments
http://img.marketwire.com/rss/mwMHSU.rss
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
announced  cfn media  company  group  marketwired oct  marketwired  media  new  oct  sciences  system  today announced  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Medical and Healthcare: Surgery and Treatments

Marketwired - Surgery and Treatments



Marketwired - Surgery and Treatments



Last Build Date: Wed, 18 Oct 2017 09:53:13 EDT

Copyright: Copyright: (C) Marketwired
 



Pressure BioSciences and Phasex Announce Strategic Collaboration Addressing Broad Markets for Stable, Water-Soluble Nanoemulsions

Wed, 18 Oct 2017 09:22:37 EDT

Companies Will Combine PBI's Recently Patented Ultra Shear Technology with Phasex's Supercritical Fluid Processing Methods to Enable Development of Stable, Water-Soluble Nanoemulsions, Including CBD-Enriched Plant Oil




Advantis Corp. Finalizes Oregon Contract, Accepts Bitcoin From Some New Customers

Wed, 18 Oct 2017 09:20:00 EDT

NEWPORT BEACH, CA--(Marketwired - Oct 18, 2017) - ADVANTIS CORPORATION (OTC PINK: ADVT) finalized the deal with a private cannabis grower in Oregon to supply Amster-Can canning and branding services. Advantis is shipping the original canning equipment to Oregon to fulfill orders at full production capacity. As Advantis grows its client base, it has decided to accept Bitcoin as payment from clients that prefer this mode of payment.




Medovex Corporation to Participate in World's Largest Spine Exhibition, NASS 2017

Wed, 18 Oct 2017 08:30:00 EDT

Company to Host Surgical Innovation Cadaver Lab with Key European and U.S. Thought Leaders for the DenerveX(R) System Technology




Viveve Releases Preliminary Third Quarter 2017 Financial Results

Wed, 18 Oct 2017 08:28:00 EDT

Record Sales and 120% Year-Over-Year Revenue Growth




Network for Regional Healthcare Improvement and the Strategic Health Information Exchange Collaborative Announce Strategic Partnership

Tue, 17 Oct 2017 09:35:00 EDT

National Leaders in Healthcare Transformation Joining Forces to Advance Policy Goals




The Hydropothecary Corporation Engages CFN Media to Develop New Investor Audience

Tue, 17 Oct 2017 09:30:00 EDT

SEATTLE, WA--(Marketwired - Oct 17, 2017) - CFN Media Group ("CFN Media", "CannabisFN"), the leading agency and digital media network dedicated to the North American cannabis industry, today announced that The Hydropothecary Corporation (TSX VENTURE: THCX) has engaged CFN Media to conduct a 3-month investor and market visibility program beginning on October 16th, 2017.




Abattis Offers a Solution to Canada's Cannabis Pesticide Problem -- CFN Media

Tue, 17 Oct 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Oct 17, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article discussing Abattis Bioceuticals Corp. (CSE: ATT) (CNSX: ATT) (CNSX: ATT.CN) (OTCQB: ATTBF), whose wholly-owned subsidiary is one of the only publicly-traded third-party cannabis testing laboratories. A steady stream of cannabis recalls has prompted regulators in Canada to call for the mandatory testing of cannabis for unauthorized pesticides. With only a handful of third-party laboratories licensed to test cannabis, these service providers are becoming increasingly important.




Viveve Announces Regulatory Approval for Viveve System in Mexico

Tue, 17 Oct 2017 08:28:00 EDT

Sexual Function Approval in Mexico Represents the Ninth New Regulatory Clearance in 2017




BioCorRx CEO Brady Granier Appears on MichaeLA on HLN to Discuss Alcohol Addiction

Tue, 17 Oct 2017 07:00:00 EDT

ANAHEIM, CA--(Marketwired - Oct 17, 2017) - BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that Brady Granier, President & CEO of BioCorRx, appeared as a guest on MichaeLA hosted by Michaela Pereira live from CNN's Los Angeles bureau, to discuss alcohol addiction and the BioCorRx® Recovery Program, which works to help people suffering from alcohol and opioid abuse disorders. The segment can be viewed in the News & Media section of the BioCorRx website. To find out more information on the BioCorRx Recovery Program please visit www.beataddiction.com.




Medigus Receives First Purchase Order From Izasa Hospital in Spain for Its MUSE System

Tue, 17 Oct 2017 07:00:00 EDT

OMER, ISRAEL--(Marketwired - Oct 17, 2017) - Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, today announced that Izasa Hospital, S.L.U., a distributor of medical products in the hospital sector, has provided an initial purchase order (PO) for the Medigus Ultrasonic Surgical Endostapler, or MUSET system. The PO covers the cost of a MUSET system console and endoscopic device, which will be available for use on patients suffering from gastroesophageal reflux disease (GERD).




The Alliance for Regenerative Medicine Releases Agenda for Fifth Annual 2017 European Advanced Therapies Investor Day

Tue, 17 Oct 2017 04:00:00 EDT

LONDON, UNITED KINGDOM and WASHINGTON, DC--(Marketwired - Oct 17, 2017) - The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy and broader regenerative medicine sector, along with co-hosts UK BioIndustry Association (BIA) and the Cell and Gene Therapy Catapult, releases the agenda for its annual European Advanced Therapies Investor Day, to be held November 9, 2017 in London.




Athletes Free to Embrace CBD After WADA Decision - But There's a Catch -- CFN Media

Mon, 16 Oct 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Oct 16, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article discussing the World Anti-Doping Agency's (WADA) recent decision to remove cannabidiol (CBD) from its list of banned substances in 2018, and that decision's ramifications for Medical Marijuana Inc.'s (OTC PINK: MJNA) subsidiary, HempMeds®.




The ALRT Diabetes Management System

Mon, 16 Oct 2017 08:30:00 EDT

Details of the patent pending diabetes management system featuring Predictive A1C and Insulin Dose Adjustment




BioElectronics Announces Independent Back Pain Clinical Study Pulsed Neuromodulation Therapy (ActiPatch) for Chronic Musculoskeletal Lower Back Pain

Mon, 16 Oct 2017 08:30:00 EDT

FREDERICK, MD--(Marketwired - Oct 16, 2017) - BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce the commencement of a clinical study investigating the efficacy of ActiPatch in treating chronic musculoskeletal lower back pain. Low back pain is highly prevalent and affects 1 in 3 adult Americans, accounting for about $ 90 billion in direct spending every year.




INmune Bio Appoints Edgardo Baracchini to its Board of Directors, Gains Additional Licensing and Business Development Expertise

Mon, 16 Oct 2017 08:30:00 EDT

LA JOLLA, CA--(Marketwired - Oct 16, 2017) - INmune Bio, Inc., a cancer immunotherapy company focused on developing therapies that harness the patient's innate immune system to attack their cancer, today announces the appointment of Edgardo "Ed" Baracchini, PhD. to its board of directors. Dr. Baracchini, the Chief Business Officer of Xencor since 2010, brings transactional and business development expertise that is well-aligned with INmune Bio's expanding product portfolio.




Nephros Provides Corporate Update and Announces Preliminary Third Quarter 2017 Revenue

Mon, 16 Oct 2017 07:30:00 EDT

Anticipates Over 90% Year-over-Year Revenue Growth in the Third Quarter and Cash Flow Breakeven around Year-End




Imagin Medical Closing Second and Final Tranche of $1,000,000 Private Placement

Fri, 13 Oct 2017 12:07:19 EDT

Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive surgery; The Company's initial focus is bladder cancer




NEMUS Bioscience Provides Further Update on Previously Announced $20 Million Schneider Financing

Fri, 13 Oct 2017 08:00:00 EDT

COSTA MESA, CA--(Marketwired - Oct 13, 2017) - NEMUS Bioscience, Inc. (OTCQB: NMUS) (the "Company") today announced a further update to its news releases dated May 4, 2017 and July 11, 2017 with respect to the signing of a private placement with Schneider Finance LLC, an affiliate of Schneider Brothers Ltd, a global closed investment fund, for the sale of 1,000,000 shares of Series E Preferred Stock of the Company for gross proceeds of $20,000,000. As previously announced, SB Securities Ltd, an affiliate of Schneider Brothers Ltd, entered into a guaranty to the benefit of the Company that guarantees the payment of the $20,000,000 investment.




Tauriga Sciences, Inc. Fully Retires Original $96,000 USD 12.00% Convertible Debenture Issued to Group 10 Holdings LLC on July 14, 2015

Fri, 13 Oct 2017 08:00:00 EDT

NEW YORK, NY--(Marketwired - Oct 13, 2017) - Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), a company engaged in building businesses in the life sciences space, today announced that it has fully retired the original face value of $96,000 USD 12.00% convertible debenture (the "Note") issued by the Company to Group 10 Holdings, LLC ("Group 10" or "Lender") on July 14, 2015. Accordingly, this debt will be removed from the Company's balance sheet.




Endonovo Receives Positive Results from Pre-Clinical Study of Non-Invasive Electroceutical

Fri, 13 Oct 2017 07:30:00 EDT

Non-Invasive Electroceutical Significantly Increased Cardiac Function and Reduced Ventricular Remodeling in Infarcted Animals




Psoriatic Arthritis' Impact Not Always Visible or Understood, Patients Say

Thu, 12 Oct 2017 13:15:00 EDT

Unseen Symptoms Frustrating to Explain to Others




InspireMD Announces Distribution Agreement for MGuard Prime(TM) in Chile

Thu, 12 Oct 2017 10:35:37 EDT

TEL AVIV, ISRAEL--(Marketwired - Oct 12, 2017) - InspireMD, Inc. (NYSE American: NSPR) (NYSE MKT: NSPR), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it has signed an agreement with CorpMedical Chile Ltda, a leading medical distributor in Chile, with its headquarters in Santiago de Chile, to distribute the MGuard PrimeT Embolic Protection System (EPS) for the treatment of acute coronary syndromes, namely Acute Myocardial Infarctions (AMI).




Avadim Technologies, Inc. Awarded Patient Cleansing and Skin Care, Bag-Based Agreement With Premier Inc.

Thu, 12 Oct 2017 09:34:32 EDT

ASHEVILLE, NC--(Marketwired - October 12, 2017) - Today, Avadim Technologies, Inc. ("Avadim"), the Bionome Therapies life sciences company, is announcing that the company has been awarded a group purchasing agreement for the Patient Cleansing and Skin Care Bag-Based category of products, with Premier Inc. Effective October 1, 2017, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Avadim's product line of packaged impregnated cloth products containing Avadim's patented, low pH, microbiome-compliant Theraworx® Technology skin care formulation.




Tauriga Sciences, Inc. & Ice + Jam LLC Confirm Timing for Formal Launch of Proprietary Cupuacu Butter Lip Balm Product to the Retail Marketplace

Thu, 12 Oct 2017 09:10:00 EDT

NEW YORK, NY--(Marketwired - Oct 12, 2017) - Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in the building of life sciences businesses and technologies, today announced with its licensor Ice + Jam LLC ("Ice + Jam"), that the Companies have selected the week of December 17, 2017 for the formal launch of "HerMan" branded product; a proprietary cupuacu butter lip balm product packaged in the industry standard cylindrical tube. The two Companies have previously announced that the label and graphics were redesigned and improved (this occurred over the past few months). The Company expects that an initial inventory of at least 10,000 HerMan units will be available to support the above-mentioned retail launch.




Plastic Surgeon in Fort Worth Highlights What to Expect During Rhinoplasty Recovery

Thu, 12 Oct 2017 09:01:00 EDT

Dr. Jon Kurkjian discusses the typical recovery and healing period most patients experience after rhinoplasty




ORHub, Inc. Announces Additional Deployment of Disruptive Surgical Information Software at Three Leading Hospitals in Southern California

Thu, 12 Oct 2017 09:00:00 EDT

increasing efficiencies, improving care and driving dramatically improved O-R economics




Rainmaker Worldwide Appoints New CFO to Take Company Through Next Phases of Growth

Thu, 12 Oct 2017 07:30:00 EDT

PETERBOROUGH, ON--(Marketwired - Oct 12, 2017) - To accelerate the company's worldwide markets over the coming years, Rainmaker (OTC: RAKR) is pleased to announce the appointment of our new CFO, Mr. Michael Dohaney.




Parkway Pantai Introduces Precision Medicine To Customise Treatment Plans For Cancer Patients

Wed, 11 Oct 2017 21:00:00 EDT

Patients to benefit from precision medicine and more accurate diagnostics in Parkway Pantai's hospitals across Asia; Acquired precision medicine platform through 55 per cent stake in Angsana Holdings




Premier Completes $207,000 Rights Offering and Reports Its Rehabilitation Clinic Thriving After Hurricane Irma and Maria

Wed, 11 Oct 2017 14:58:00 EDT

VANCOUVER BC--(Marketwired - October 11, 2017) - Premier Health Group Inc (the "Company") is pleased to announce the closing of the rights offering issued to shareholders April 17, 2017, resulting in the issuance of 207,000 shares at an exercise price of $1.00 per share for total consideration of $207,000. Proceeds will be used for working capital purposes. The Company is pleased to announce its multidisciplinary rehabilitation facility in Santiago Dominican Republic was unscathed by hurricane Irma and Maria and management expansion of the clinics is now in the planning stage. The Company has resolved issues with accounting delays and is proceeding to update its application to seek a listing.




GeoVax Reports Significant Advance in HIV Vaccine Development

Wed, 11 Oct 2017 14:00:00 EDT

Elicitation of a Key Precursor for Broadly Neutralizing Antibody for the HIV CD4 Binding Site




Tauriga Sciences, Inc. Fully Repays $45,000 USD Face Value Convertible Debenture for One-Time Cash Payment of $72,457.89 USD & Conditional Deferred Issuance of 10,000,000 Shares

Wed, 11 Oct 2017 12:04:48 EDT

NEW YORK, NY--(Marketwired - Oct 11, 2017) - Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building businesses in the life sciences space, today announced that is has fully repaid and retired a $45,000 face value 12% convertible debenture (the "Note") held by Group 10 Holdings, LLC ("Group 10"). This convertible debenture, which was issued by the Company on November 7, 2016 and was due on November 8, 2017, has been fully repaid for a one-time cash payment of $72,457.89 received by Group 10 on October 10, 2017. Accordingly, this debt will be removed from the Company's balance sheet.




Urologists Invest in Imagin Medical Private Placement

Wed, 11 Oct 2017 11:22:50 EDT

Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive surgery; The Company's initial focus is bladder cancer




FDS Achieves Pharmacist eCare Plan Level I Capability

Wed, 11 Oct 2017 11:02:41 EDT

FDS Expands its Portfolio of Patient Care Offerings in Support of Care Coordination and Enhanced Pharmacy Services